J. D. Gangemi

发表

Poly I:C‐Induced Anti‐Herpes Simplex Virus Type 1 Activity in Inflammatory Macrophages Is Mediated by Induction of Interferon‐β

S. Pyo, E. Mayer, J. D. Gangemi, 1991, Journal of leukocyte biology.

Functional inactivation but not structural mutation of p53 causes liver cancer

S. Ullrich, G. Jay, H. Ueda, 1995, Nature Genetics.

Immunogenicity and safety of recombinantHelicobacter pylori urease in a nonhuman primate

T. Monath, C. Stadtländer, Cynthia Lee, 1996, Digestive Diseases and Sciences.

Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine.

E. De Clercq, M. Monsigny, J. Balzarini, 1990, Biochemical and biophysical research communications.

HPV replication in experimental models: effects of interferon.

J. Kreider, L. Pirisi, J. D. Gangemi, 1994, Antiviral research.

IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression.

H. Hochkeppel, J. Johnson, J. D. Gangemi, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Bronchoalveolar lavage and the immunology of primary lung cancer.

J. D. Gangemi, G. Olsen, G. N. Olsen, 1985, Chest.

Effect of interferon α and cell cycle progression on translation mediated by the hepatitis C virus 5′ untranslated region: a study using a transgenic mouse model

M. Yano, H. Asakura, G. Jay, 2004, Journal of viral hepatitis.

Enhancement of Natural Resistance to Influenza Virus in Lipopolysaccharide-Responsive and -Nonresponsive Mice by Propionibacterium acnes

M. G. Welsh, J. D. Gangemi, M. Sigel, 1983, Infection and immunity.

Alpha Interferon Augments Cidofovir's Antiviral and Antiproliferative Activities

J. Johnson, J. D. Gangemi, 2003, Antimicrobial Agents and Chemotherapy.

Comparison of cefamandole and cefazolin during cardiopulmonary bypass.

C. Bryan, J. Sutton, C. Smith, 1983, The Journal of thoracic and cardiovascular surgery.

Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells.

U. Wintergerst, R. Whitley, E. Kern, 1996, Antiviral research.

Use of a restriction endonuclease in analyzing the genomes from two different strains of vaccinia virus

D. Sharp, J. D. Gangemi, 1976, Journal of virology.

Mycoplasma penetrans and Other Mycoplasmas in Urine of Human Immunodeficiency Virus-Positive Children

W. Robson, A. Hussain, J. D. Gangemi, 1999, Journal of Clinical Microbiology.

9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections

E. De Clercq, R. Cozens, H. Hochkeppel, 1989, Antimicrobial Agents and Chemotherapy.

Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus.

J. D. Gangemi, M. Nachtigal, D. Barnhart, 1987, The Journal of infectious diseases.

Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.

U. Reichl, Y. Genzel, T. Vogel, 2014, Vaccine.

Poly I:C-induced antiviral and cytotoxic activities are mediated by different mechanisms.

S. Pyo, E. Mayer, J. D. Gangemi, 1993, International journal of immunopharmacology.

Opsonization of alphaviruses in hamsters

P. Jahrling, R. Hesse, A. Anderson, 1983, Journal of medical virology.

Enhanced Antiviral Benefit of Combination Therapy with Lamivudine and Alpha Interferon against WHV Replication in Chronic Carrier Woodchucks

R. Schinazi, B. Tennant, J. Gerin, 1999, Antiviral therapy.

Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.

E. De Clercq, E. Kern, E. Mayer, 1991, Antiviral research.

Selective Inhibition of Human Papillomavirus-Induced Cell Proliferation by (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine

J. D. Gangemi, J. Johnson, 1999, Antimicrobial Agents and Chemotherapy.

Effect of recombinant human interferon α B/D (rHu-IFN-α B/D) in combination with acyclovir in experimental HSV-1 encephalitis

U. Wintergerst, R. Whitley, E. Kern, 1999 .

Antiviral activity of a novel recombinant human interferon-αB/D hybrid

H. Hochkeppel, A. Matter, F. Dietrich, 1989 .

Novel Approaches for Targeting Antiviral Agents in the Treatment of Arena-, Bunya-, Flavi-, and Retroviral Infections

E. Mayer, J. D. Gangemi, A. Ghaffar, 1989 .

Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections.

H. Hochkeppel, J. D. Gangemi, B. Poncioni, 1989, Journal of interferon research.

Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery

C. Bryan, J. Sutton, C. Smith, 1984, Antimicrobial Agents and Chemotherapy.

Suppressive effects of 3-methylcholanthrene on the in vitro antitumor activity of naturally cytotoxic cells.

J. D. Gangemi, P. Lill, 1986, Journal of Toxicology and Environmental Health, Part A.

Ineffectiveness of Echinacea for Prevention of Experimental Rhinovirus Colds

R. Turner, J. D. Gangemi, D. K. Riker, 2000, Antimicrobial Agents and Chemotherapy.

Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons

W. Tolleson, L. Pirisi, M. Khan, 1993, Journal of virology.

Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.

H. Hochkeppel, A. Matter, F. Dietrich, 1989, Journal of interferon research.

Cross‐Species Antiviral Activity of a Recombinant Human Alpha‐Interferon Hybrid a

H. Hochkeppel, S. Pyo, E. Mayer, 1992, Annals of the New York Academy of Sciences.

Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma

J. D. Gangemi, C. Bauguess, J. Hightower, 2004, Cancer Immunology, Immunotherapy.

Host-induced influences on the syntheses of defective vaccinia particles.

D. Sharp, J. D. Gangemi, 1976, Virology.

Role of Pulmonary Macrophages in Resistance to Experimental Metastasis

R. A. Jackson, J. D. Gangemi, P. Lill, 1986, Journal of Leukocyte Biology.

Experimentally induced infection with Helicobacter pylori in squirrel monkeys (Saimiri spp.): clinical, microbiological, and histopathologic findings.

T. Monath, C. Stadtländer, F. Stutzenberger, 1998, Laboratory animal science.

Arenavirus Concentration by Molecular Filtration

G. Eddy, B. G. Mahlandt, J. D. Gangemi, 1977, Applied and environmental microbiology.

Structural polypeptides of Machupo virus.

R. Rosato, G. Eddy, J. D. Gangemi, 1978, The Journal of general virology.

Polypeptide synthesis catalysed by components of Pichinde virus disrupted by detergent.

H. A. Thompson, D. N. Chinault, J. D. Gangemi, 1981, The Journal of general virology.

Production of Venezuelan equine encephalitis virus in cells grown on artificial capillaries

A. D. Johnson, G. Eddy, H. H. Ramsburg, 1978, Applied and environmental microbiology.

Lipopolysaccharide‐induced suppression of erythrocyte binding and phagocytosis via FCγRI, FCγRII, FCγRIII, and CR3 receptors in murine macrophages

M. O'connor, J. D. Gangemi, A. Ghaffar, 1993, Journal of leukocyte biology.

Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects.

E. Alteri, J. Lazdins, J. D. Gangemi, 1990, Antiviral Research.

Changes in buoyant density relationships of two cell types of Coxiella burneti phase I

R. Wachter, C. E. Pedersen, J. D. Gangemi, 1975, Infection and immunity.

Changes inBuoyant Density Relationships ofTwoCellTypesof Coxiella burneti PhaseI

R. Wachter, C. E. Pedersen, J. D. Gangemi, 1975 .

An ultrastructural examination of murine alveolar macrophages following intranasal administration of propionibacterium acnes.

R. A. Jackson, M. G. Welsh, J. D. Gangemi, 1987, Histology and histopathology.

Particle heterogeneity in vaccinia virus populations during passage.

D. Sharp, J. D. Gangemi, 1978, Virology.